Global qPCR and dPCR Market Forecast up to 2025
- February, 2019
- Domain: Healthcare - Biotechnology
- Get Free 10% Customization in this Report
Overview of the Global qPCR and dPCR Market Research
Infoholic’s Market Research Report predicts that the Global qPCR and dPCR Market will grow at a CAGR of 9.2% during the forecast period. The market has witnessed steady growth in the past few years and development in technology with the introduction of highly sensitive, robust, and reliable systems in the market. The market is fueled by rising demand for qPCR and dPCR in genetic and molecular testing, increasing private investment and funds, and increasing demand for biomarker-based tests.
The market continues to grow and is one of the most widely used technology for the quantification of nucleic acid. The advanced technology has made the device simple, fast, and accurate. Vendors are focusing towards new product launches and targeting towards end-user’s perspective. The majority of the revenue is generated from the leading players in the market with dominating sales of Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., Abbott Laboratories, Danaher Corporation and F. Hoffmann-La Roche Ltd.
According to Infoholic Research analysis, North America accounted for the largest share of the Global qPCR and dPCR Market in 2018. The increased usage of PCR in proteomics & genomics, advanced technologies such as qPCR and PCR-based laboratory developed tests for rare genetic diseases, cancers, and infectious diseases are driving the market in North America. The Asia Pacific region is expected to witness the fastest growth rate due to large patient pool and rising healthcare expenditure.
By Product Type
- Reagents and Consumables
- Software and Services
In 2018, the reagents and consumables segment occupied the largest share due to its advanced features and specialty-based operations. Many companies are focusing on providing even software services. In March 2017, ThermoFisher Scientific acquired Core Informatics, a provider of cloud-based platform supporting scientific data management.
- Clinical Diagnostics
- Biomedical Research
In 2018, the Biomedical Research accounted the maximum share followed by the clinical diagnostics. The successful completion of Human genome project has driven the growth of qPCR and dPCR Market.
By Technology Type
- Qualitative PCR
- Digital PCR
qPCR has become the standard method for quantification of gene expression. Its high sensitivity, large dynamic range, and accuracy has led to the development of numerous applications with an increasing number of samples to be analyzed.
By End Users
- Hospitals and Laboratories
- Pharmaceutical Companies
In 2018, academics segment gained the highest market share for qPCR and dPCR Market due to increased use of technology in the field of research.
- North America
The market is dominated by North America, followed by Europe and Asia Pacific. The major share of the North America market is from the US due to the quick adoption of new and advanced technologies.
qPCR and dPCR Market Research Competitive Analysis – The PCR is a matured technology, innovation in the instruments, reagents, and software is essential to maintain their market position. However, this doesn’t signify lack of improvement in both instruments and reagents. Superior sensitivity, improved multiplexing, better cDNA synthesis, and greater projectivity are the major features looked upon by the end-users of the market.
Merger and acquisition have been major strategy followed by key players in the market to maintain their leadership in the market. In 2016, Thermo Fisher Scientific deployed around $5.5 billion on acquisitions. This is expected to increase the offerings and strategic positioning of the company. The company increased its Life Sciences Solutions business by acquiring Affymetrix. In early 2017, Bio-Rad Laboratories, leader in digital PCR acquired RainDance Technologies, the fastest growing company in dPCR and liquid biopsy markets.
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Danaher Corp.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Hoffmann-La Roche
- Abbott Laboratories
- Promega Corp.
- Eppendorf AG
- BioMerieux S.A.
- Merck KGaA
Key competitive facts
- The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, and the prices are key factors that confront the market.
- The requirement of high investment for the installation of the qPCR and specially the dPCR instruments are hampering the growth of the market.
Benefits – The report provides complete details about the usage and adoption rate of qPCR and dPCR Market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives towards the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.
- Understanding the potential market opportunity with precise market size and forecast data
- Detailed market analysis focusing on the growth of qPCR and dPCR industry
- Factors influencing the growth of qPCR and dPCR market
- In-depth competitive analysis of dominant and pure play vendors
- Prediction analysis of qPCR and dPCR industry in both developed and developing regions
- Key insights related to major segments of the qPCR and dPCR market
- Latest market trend analysis impacting the buying behavior of the consumers
Key Stakeholders –
1.1 Industry Overview
1.2 Total Addressable Market
1.2.1 Industry Trends
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Segmented Addressable Market (SAM)
3.2.1 Strengths of dPCR and qPCR
3.2.2 Application of Digital PCR Applications
3.2.3 Emerging Applications of Droplet Digital PCR
3.3 Industry Trends
3.4 Related Markets
3.4.1 In-Vitro Diagnostics
184.108.40.206 Industry trends
3.4.2 Liquid Biopsy Market
220.127.116.11 Trends of liquid biopsy market
3.4.3 Next-Generation Sequencing
18.104.22.168 Trends in the next-generation sequencing market
4 Market Outlook
4.1 Infectious Diseases detected by qPCR and ddPCR
4.2 Porter 5 (Five) Forces
5 Market Characteristics
5.2 Market Segmentation
5.3 Market Dynamics
22.214.171.124 Rising demand for qPCR and dPCR in genetic and molecular testing
126.96.36.199 Increasing in private investment and funds
188.8.131.52 Increasing demand for biomarker-based tests
184.108.40.206 Lack of skilled professionals
220.127.116.11 High cost of the qPCR and dPCR instruments
18.104.22.168 Growth of personalized medicines
22.214.171.124 Market expansion opportunities in emerging nations
5.3.4 DRO – Impact Analysis
5.4 Key Stakeholders
6 Technology Types: Market Size and Analysis
6.2 Digital Polymerase Chain Reaction
6.3 Real-Time/Quantitative Polymerase Chain Reaction
7 Product Types: Market Size and Analysis
7.3 Reagents and Consumables
7.4 Software and Services
8 Application: Market Size and Analysis
8.2 Clinical Diagnostics
8.3 Biomedical Research
9 End Users: Market Size and Analysis
9.2 Hospitals and Laboratories
9.3 Pharmaceutical Companies
10 Regions: Market Size and Analysis
10.2 North America
10.4 Asia Pacific
10.5 Rest of the World
11 Competitive Landscape
12 Vendors Profile
12.1 Thermo Fisher Scientific, Inc.
12.1.2 Business Units
12.1.3 Geographic Revenue
12.1.4 Business Focus
12.1.5 SWOT Analysis
12.1.6 Business Strategy
12.2 F. Hoffmann-La Roche Ltd.
12.2.2 Business Units
12.2.3 Geographic Revenue
12.2.4 Business Focus
12.2.5 SWOT Analysis
12.2.6 Business Strategies
12.3 Abbott Laboratories
12.3.2 Business Units
12.3.3 Geographic Revenue
12.3.4 Business Focus
12.3.5 SWOT Analysis
12.3.6 Business Strategies
12.4 Qiagen N.V.
12.4.2 Business Units
12.4.3 Geographic Revenue
12.4.4 Business Focus
12.4.5 SWOT Analysis
12.4.6 Business Strategies
12.5 Bio-Rad Laboratories
12.5.2 Business Units
12.5.3 Geographic Revenue
12.5.4 Business Focus
12.5.5 SWOT Analysis
12.5.6 Business Strategies
13 Companies to Watch for
13.1 Agilent Technologies Inc.
13.2 Promega Corp.
13.3 Eppendorf AG
13.4 BioMerieux S.A.
13.5 Merck KGaA
13.6 Danaher Corp. (Cepheid)
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
Market related information is congregated from both primary and secondary sources.
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.